Profiles of Drug Substances, Excipients and Related Methodology 2013-05-01

Paroxetine hydrochloride: polymorphs and solvatomorphs.

HarryG Brittain

Index: Profiles Drug Subst. Excip. Relat. Methodol. 38 , 407-21, (2013)

Full Text: HTML

Abstract

The polymorphic (crystal systems for which a substance can exist in structures defined by different unit cells, and where each of the forms has the same elemental composition) and solvatomorphic (systems where the crystal structures of the substance are defined by different unit cells, but where these unit cells differ in their elemental composition through the inclusion of one or molecules of solvent) landscape of paroxetine hydrochloride have been critically evaluated in order to learn how many authentic crystal forms have actually been discovered. After a survey of the patent and open literature, it was determined that paroxetine hydrochloride has been crystallized in four genuine nonsolvated polymorphic forms and in four fully characterized solvatomorphic forms.


Related Compounds

Related Articles:

A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.

2013-02-01

[J. Clin. Psychopharmacol. 33(1) , 3-10, (2013)]

Chronic angle-closure glaucoma related to paroxetine treatment.

2013-07-01

[Semin. Ophthalmol. 28(4) , 244-6, (2013)]

Paroxetine (Brisdelle) for hot flashes.

2013-10-28

[Med. Lett. Drugs Ther. 55(1428) , 85-6, (2013)]

FDA Approval of Paroxetine for Menopausal Hot Flushes

2014-05-08

[N. Engl. J. Med. 370(19) , 1777-9, (2014)]

Serotonin and yawning: a potential adverse drug reaction during antidepressant therapy

2013-10-16

[Presse Med. 43(10 Pt 1) , 1135-6, (2014)]

More Articles...